Correlation Between Entrada Therapeutics and MediciNova

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Entrada Therapeutics and MediciNova at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Entrada Therapeutics and MediciNova into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Entrada Therapeutics and MediciNova, you can compare the effects of market volatilities on Entrada Therapeutics and MediciNova and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Entrada Therapeutics with a short position of MediciNova. Check out your portfolio center. Please also check ongoing floating volatility patterns of Entrada Therapeutics and MediciNova.

Diversification Opportunities for Entrada Therapeutics and MediciNova

-0.11
  Correlation Coefficient

Good diversification

The 3 months correlation between Entrada and MediciNova is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Entrada Therapeutics and MediciNova in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MediciNova and Entrada Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Entrada Therapeutics are associated (or correlated) with MediciNova. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MediciNova has no effect on the direction of Entrada Therapeutics i.e., Entrada Therapeutics and MediciNova go up and down completely randomly.

Pair Corralation between Entrada Therapeutics and MediciNova

Given the investment horizon of 90 days Entrada Therapeutics is expected to generate 1.2 times less return on investment than MediciNova. But when comparing it to its historical volatility, Entrada Therapeutics is 3.39 times less risky than MediciNova. It trades about 0.16 of its potential returns per unit of risk. MediciNova is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  191.00  in MediciNova on August 28, 2024 and sell it today you would earn a total of  17.00  from holding MediciNova or generate 8.9% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Entrada Therapeutics  vs.  MediciNova

 Performance 
       Timeline  
Entrada Therapeutics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Entrada Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating fundamental indicators, Entrada Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.
MediciNova 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in MediciNova are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, MediciNova showed solid returns over the last few months and may actually be approaching a breakup point.

Entrada Therapeutics and MediciNova Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Entrada Therapeutics and MediciNova

The main advantage of trading using opposite Entrada Therapeutics and MediciNova positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Entrada Therapeutics position performs unexpectedly, MediciNova can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MediciNova will offset losses from the drop in MediciNova's long position.
The idea behind Entrada Therapeutics and MediciNova pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum